Before starting his career in strategy consulting with the Boston Consulting Group in Munich (Germany), Dr. Leewe had already worked 9 years in the industry. He was the head of Finance and Controlling of Fresenius Medical Care Latin America based in Miami (USA). Originally, he was a member of Lufthansa Cargo's high potential program "Pro Team" in Frankfurt (Germany) and Atlanta (USA). Dr. Leewe has spoken at numerous conferences on the European health care market, strategy development, the health care logistics market and frequently acted as an expert and evaluator on startup companies. He is a co-author of one of the leading medical technology books.

Dr. Leewe founded Novumed Life Science Consulting in 2004. He studied European Business Administration at ICADE in Madrid (Spain) and at the ESB in Reutlingen (Germany). He holds a PhD in Business Administration from Loughborough University (UK).

Dr. Bayrhoffer's experience spans the diverse areas of strategic and financial advisory, market research and business analysis, clinical development, and business development. He started his career at the Boston Consulting Group (BCG) where he worked primarily in the Life Sciences Practice. He has helped clients with organizational change, business re-engineering, and commercialization strategies. Dr. Bayrhoffer has also worked in an advisory and PE firm focused on the mid-size market and leadership positions in clinical development organizations and imaging core labs. Recently he led US client engagements for a global commercial analytics and consulting organization focused on the pharmaceutical industry.

Dr. Bayrhoffer is a physician by training with a MD from the University of Mainz (Germany) and also holds a MBA from the Simon School at the University of Rochester, NY (USA).

Dr. Anthony received his doctorate in Microbiology from the University of Texas, where he focused on the structure/function relationship of virus and host interaction. After a post-doc at the University of Southern California School of Medicine, he started his industry career with a small biotech start-up working in anti-viral drug R&D. He transitioned to clinical development after joining the US division of Mitsubishi Pharma Inc. where he led US development of cardiovascular and oncology drugs. In 1999 he founded a contract research organization (CRO), Catalyst Pharma Group Inc., providing pharmaceutical, biotechnology and medical device companies services that included preparing regulatory submissions for the FDA, EMEA, and MHLW, designing, managing and analyzing all phases of clinical research trials, and arranging licensing opportunities for client's products. He is also the founder and board member of Topica Pharmaceuticals Inc. (formerly Janus Pharmaceuticals Inc.), a speciality pharmaceutical company in northern California.

His familiarity with both sides of the medical product development process after numerous clinical trials, both in the US and abroad, provides a unique perspective to understanding the clinical, regulatory, and business complexities of today's medical product development environment.  Dr. Anthony has spoken at numerous national meetings on the topics of Peripheral arterial disease (PAD), patient recruitment, electronic data collection, IND filing, clinical trial design and ethical issues intrinsic to human research.